Home › Stocks › CTMX › All Fund Holders
CTMX — CYTOMX THERAPEUTICS INC. · All Fund Holders
Funds holding (latest): 36 · Reported value held: $458.53M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Fidelity Management & Research (FMR) history | Q2 2026 | 32.71M | $122.68M | 0.01% | Add |
| BlackRock Inc history | Q2 2026 | 17.56M | $65.85M | 0.00% | Add |
| Bank of America Corp history | Q2 2026 | 15.08M | $56.56M | 0.00% | Add |
| Vanguard Group history | Q4 2025 | 8.48M | $36.11M | 0.00% | Reduce |
| Point72 Asset Management history | Q2 2026 | 7.81M | $29.29M | 0.03% | Reduce |
| Wellington Management Group history | Q2 2026 | 5.17M | $19.38M | 0.00% | Add |
| Geode Capital Management history | Q2 2026 | 4.68M | $17.55M | 0.00% | Add |
| Two Sigma Investments history | Q2 2026 | 4.13M | $15.50M | 0.01% | Add |
| Franklin Resources history | Q2 2025 | 5.77M | $13.10M | 0.00% | New |
| UBS Group AG history | Q2 2026 | 3.47M | $13.01M | 0.00% | Add |
| Citadel Advisors history | Q2 2026 | 3.33M | $12.49M | 0.00% | Reduce |
| Marshall Wace history | Q2 2026 | 3.02M | $11.34M | 0.01% | Reduce |
| Renaissance Technologies history | Q3 2025 | 2.55M | $8.12M | 0.01% | Add |
| Goldman Sachs Group history | Q2 2026 | 2.00M | $7.51M | 0.00% | Add |
| Millennium Management history | Q2 2026 | 1.69M | $6.32M | 0.00% | Reduce |
| Northern Trust Corp history | Q2 2026 | 1.68M | $6.28M | 0.00% | Add |
| Balyasny Asset Management history | Q1 2026 | 730.84K | $3.43M | 0.01% | Reduce |
| BNY Mellon history | Q2 2026 | 684.54K | $2.57M | 0.00% | Add |
| Deutsche Bank AG history | Q2 2026 | 663.04K | $2.49M | 0.00% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 549.88K | $2.06M | 0.00% | Add |
| MFS Investment Management history | Q4 2021 | 357.13K | $1.55M | 0.00% | Reduce |
| Citigroup Inc history | Q2 2026 | 287.87K | $1.08M | 0.00% | Add |
| Invesco Ltd history | Q2 2026 | 220.21K | $825.77K | 0.00% | Add |
| Morgan Stanley history | Q2 2026 | 190.80K | $715.50K | 0.00% | Reduce |
| Wells Fargo & Co history | Q2 2026 | 163.18K | $611.94K | 0.00% | Add |
| CPP Investments history | Q2 2026 | 141.50K | $530.62K | 0.00% | Add |
| Legal & General Investment Management America history | Q2 2026 | 123.31K | $462.42K | 0.00% | Reduce |
| JPMorgan Chase & Co history | Q2 2026 | 109.41K | $409.20K | 0.00% | New |
| Janus Henderson Group history | Q1 2026 | 46.70K | $219.72K | 0.00% | New |
| Manulife Financial history | Q2 2026 | 47.80K | $179.23K | 0.00% | New |
| AQR Capital Management history | Q2 2026 | 42.01K | $157.55K | 0.00% | New |
| Prudential Financial history | Q2 2026 | 27.95K | $104.81K | 0.00% | New |
| Principal Global Investors history | Q1 2022 | 10.81K | $29.00K | 0.00% | Add |
| D. E. Shaw & Co history | Q1 2024 | 10.81K | $23.57K | 0.00% | Reduce |
| T. Rowe Price Associates history | Q2 2026 | 148.11K | $556 | 0.00% | New |
| Lazard Asset Management history | Q2 2025 | 43.32K | $98 | 0.00% | Add |